Triblock Copolymer Gene Delivery via Segmented Self-Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current delivery systems for nucleic acids, such as siRNA, face challenges in efficiently targeting and internalizing into cells due to issues like toxicity, aggregation, and endosomal escape, limiting their therapeutic potential for applications like gene silencing and tissue regeneration.
Innovation Solution
Development of triblock copolymers with a hydrophilic, hydrophobic, and positively charged block structure that self-assemble into supramolecular structures like micelles or vesicles, allowing for reversible complexation with nucleic acids and enhanced cellular uptake, utilizing PEG, PPS, and peptides like TAT for efficient delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cationic polymers are used for gene delivery, then nucleic acid complexation is achieved, but toxicity and aggregation occur
Solution Approach 1:
The cationic polymer is segmented into three distinct blocks: a hydrophilic block (PEG or PO) for solubility and biocompatibility, a hydrophobic block (PPS) for structural stability, and a cationic block (peptide or polyamine) for nucleic acid binding. This segmentation allows each block to perform its specific function while minimizing harmful effects.
Solution Approach 2:
Different regions of the polymer have different properties: the hydrophilic block provides water solubility and reduces toxicity, the hydrophobic block provides structural stability, and the cationic block provides nucleic acid binding capability. This local differentiation of properties resolves the contradiction between delivery efficiency and toxicity.
2Reliability
If cationic polymers self-assemble with nucleic acids, then complexation is formed, but aggregation occurs
Solution Approach 1:
The polymer is divided into functional segments where the hydrophilic block maintains solubility and prevents aggregation, the hydrophobic block provides structural integrity, and the cationic block handles nucleic acid binding. This segmentation prevents the formation of large aggregates while maintaining effective complexation.
Solution Approach 2:
The polymer's molecular weight, block ratios, and composition are optimized to control the self-assembly process. By adjusting these parameters, the system forms stable complexes without excessive aggregation, achieving both effective nucleic acid binding and compositional stability.
3Productivity
If viral vectors are used for gene delivery, then efficient internalization is achieved, but safety and immunogenicity issues arise
Solution Approach 1:
The patent uses synthetic polymers instead of complex viral vectors. These polymer-based delivery systems are simpler, non-immunogenic, and can be easily modified, avoiding the safety and immunogenicity issues associated with viral vectors while maintaining efficient internalization through endocytosis.
Solution Approach 2:
The cationic polymer acts as an intermediary carrier that facilitates nucleic acid internalization without requiring viral components. The polymer complexes with nucleic acids and mediates their uptake into cells through endocytosis, achieving efficient delivery without the immunogenicity of viral vectors.
4Productivity
If endosomal escape is enhanced, then cytoplasmic delivery is improved, but cellular toxicity increases
Solution Approach 1:
The polymer's structure and function are made dynamic: the hydrophilic block provides water solubility and reduces toxicity, the hydrophobic block provides structural stability, and the cationic block provides nucleic acid binding. This dynamic design allows the system to navigate the endosomal pathway and achieve cytoplasmic delivery while minimizing cellular toxicity through the hydrophilic block's protective effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The triblock copolymer system enables effective internalization and release of nucleic acids within cells, overcoming previous delivery limitations and achieving significant gene silencing and therapeutic effects, such as downregulating target genes for conditions like postsurgical adhesions.
Implementation Method 1
a positively charged block capable of reversibly complexing a negatively charged molecule, e.g., a nucleic acid
Implementation Method 2
Polymers with novel triblock structures, containing spatially separated hydrophobic and hydrophilic parts, have been developed for the effective delivery of negatively charged molecules
Implementation Method 3
a hydrophobic block disposed between the hydrophilic block and the positively charged block
Data Source
Figure 1
Figure 2
Figure 3A~3E
AI summary
The invention features a triblock copolymer including a hydrophilic block; a hydrophobic block; and a positively charged block capable of reversibly complexing a negatively charged molecule, e.g., a nucleic acid, wherein the hydrophobic block is disposed between the hydrophilic block and the positively charged block. Desirably, the triblock copolymer is capable of self-assembling into a supramolecular structure, such as a micelle or vesicle. The invention further features methods of delivering negatively charged molecules and methods of treating a disease or condition using the polymers of the invention.